Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Secure Blockchain Development Corp
V.ID
Alternate Symbol(s):
IDBDF
Technology
Software - Application
Secure Blockchain Development Corp. engages in the research, design, and development of an email encryption software solution. It provides Delivery Trust, an email encryption technology software that targets organizations, as well as individuals, including medical professionals, insurance companies, accountants, lawyers, real estate agents, and educators. The company was formerly known as...
Identillect Technologies Corp. and changed its name to Secure Blockchain Development Corp. in October 2025. The company is based in Poway, California.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSXV:ID)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(21)
•••
Tiberian1234
X
Post by
Tiberian1234
on Mar 27, 2022 7:00pm
Will this stock move
Now that crypto is rising?
(21)
•••
Tiberian1234
X
Comment by
Tiberian1234
on Mar 17, 2022 2:59pm
RE:very surprised they are even hear anymore
Do you even know what this company does?
BioVaxys & Adiverna Enter Collaboration to Develop Companion Animals Vaccines
posted Mar 10, 2026 9:00am by
BioVaxys Technology Corp.
-
|
“We are very excited to be working with Adiverna to develop what could be the world’s first mRNA veterinary vaccine. We believe the clinically proven advantages of the DPX platform formulated with Adiverna’s AI-designed mRNA sequences will provide for a superior product, adds Kovan. “With demonstrated in vivo proof of concept of DPX mRNA formulations, this ‘proof of product’ will further our partnering discussions utilizing DPX mRNA formulations in human therapeutic applications.” ...read more
(21)
•••
Tiberian1234
X
Comment by
Tiberian1234
on Mar 10, 2022 4:25pm
RE:come on they are only in to it for the pay day
What's a dud? This is going to be big I think.
(11)
•••
swim
X
Post by
swim
on Mar 03, 2022 9:02am
Project Hospitality Chooses Identillect Technologies to Incr
DANA POINT, CA / ACCESSWIRE / March 3, 2022 / Identillect Technologies Corp. (the "Company" or "Identillect") (TSXV:ID)(FSE:8ID), an industry leader in compliant email
...more
(21)
•••
Tiberian1234
X
Comment by
Tiberian1234
on Feb 18, 2022 6:40pm
RE:Roll it Back; Roll it Back 40 old for 1 new
One positive NR and it will sky
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Team spotlight: Q+A: Charlene Duffett, Viridian Metals exploration manager
Freegold Ventures reports results from six additional drill holes at its Golden Summit project
BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines
Podcasts